While domestic market demand is strong, analysts expect higher raw material and freight costs to affect business in US, other countries; healthy YoY growth seen in hospitals and diagnostics
Ranbaxy promoters Malvinder and Shivinder Singh have been in the news for wrong reasons. The latest development is one more chapter in the story of their downfall. Here's a peek into their journey
Stocks to watch today: Bharti Airtel and Adani Ports will report their June quarter results (Q1FY23); Titan saw 13-fold jump in net profit to Rs 790 crore in Q1FY23.
Fortis Healthcare has reported 69 per cent decline in consolidated net profit at Rs 134 crore for the first quarter ended June 30
Stocks to Watch: With oil prices staging a dramatic reversal, related stocks, along with rate-sensitive sectors will be on the radar as RBI announces its monetary policy outcome Friday.
Stocks to watch today: IT behemoth TCS net profit grew 5.2 per cent year-on-year (YoY) to Rs 9,478 crore in Q1FY23; Tata Motors hiked prices across passenger vehicle range by 0.55 per cent.
Fortis Healthcare Ltd plans to add around 1,500 new beds to its network to take the total to around 5,000 beds in the next three years, according to company officials. The company has also lined up a capex of Rs 400 crore for the ongoing fiscal which will be divided equally on maintenance and growth programmes. The healthcare chain is continuing with its portfolio rationalisation programme aligning with its focus on cluster approach to grow both organically via brownfield expansion and inorganically in geographies of Delhi-NCR, Maharashtra, Bangalore and Kolkata, Fortis Healthcare Ltd Managing Director and CEO Ashutosh Raghuvanshi told analysts. "Our plans to add 1,200 beds in the existing facilities over the next few years are well underway," he said. Elaborating on the new beds addition programme, Fortis Healthcare CFO Vivek Kumar Goyal said at present the company had 4,000 beds and the target is to reach around 5,000 beds in the next three years. Stating that the company's "1,3
Market regulator SEBI slapped a fine on Fortis Healthcare subsidiaries on account of fund diversion by erstwhile promoters
The case pertains to misappropriation of funds by the erstwhile promoters and their related entities from Fortis Healthcare
Initiative provides counselling, webinars to create a culture of openness and acceptance about mental health and real-time text chat support by a team of psychologists
From nil revenues, it has already climbed back to 50% of pre-pandemic levels
Fortis Healthcare on Friday said its consolidated profit after tax (PAT) rose by over twofold to Rs 142 crore in the third quarter ended December 31, 2021. The company had reported a PAT of Rs 54 crore in the corresponding period last fiscal. Its revenue during October-December 2021 rose to Rs 1,466.7 crore as compared with Rs 1,177 crore in the year-ago period, Fortis Healthcare said in a statement. "Our efforts to drive operations both in terms of revenue accretion and cost optimisation initiatives have yielded positive results as witnessed in the Q3 performance and over the past few quarters," Ravi Rajagopal, chairman (board of directors) of Fortis Healthcare, said. Strategic plans for further strengthening clinical specialities, medical programmes and infrastructure are actively being pursued, he added. "Investments in brownfield (existing) bed expansion should see the company add close to 250-300 beds each year for the next few years, taking our operational bed capacity to ov
IHH acquired a 31 per cent controlling stake in Fortis Healthcare in 2018 following a prominent bidding war against domestic and international companies.
The apex court now posted the matter for hearing on December 15
Experts flag privacy concerns in absence of data protection law
Healthcare companies to post decent growth in revenues in Q3FY21
The company had posted a net profit of Rs 124.04 crore for the corresponding period of the previous fiscal
WF Asian Smaller Companies Fund Ltd on Monday sold shares of Fortis Healthcare Ltd worth over Rs 50 crore through an open market transaction.
License agreement of Fortis, SRL brands expire in 2021
Its consolidated income from operations stood at Rs 605.95 crore for the quarter under consideration